“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy

Harris, 2000, Control group selection is an important but neglected issue in studies of antibiotic resistance [letter], Ann Intern Med, 132, 925, 10.7326/0003-4819-132-11-200006060-00024

Harris, 2001, Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review, Clin Infect Dis, 32, 1055, 10.1086/319600

Harris, 2002, Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli, Clin Infect Dis, 34, 1558, 10.1086/340533

Paterson, 2002, Looking for risk factors for the acquisition of antibiotic resistance: a 21st-century approach, Clin Infect Dis, 34, 1564, 10.1086/340532

Harbarth, 2001, Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli, Clin Infect Dis, 33, 1462, 10.1086/322677

Donskey, 2000, Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract, J Infect Dis, 181, 1830, 10.1086/315428

Pallares, 1993, Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study, Arch Intern Med, 153, 1581, 10.1001/archinte.1993.00410130103010

Dahms, 1998, Third-generation cephalosporins and vancomycin as risk factors for postoperative vancomycin-resistant enterococcus infection, Arch Surg, 133, 1343, 10.1001/archsurg.133.12.1343

Ostrowsky, 1999, Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period, Arch Intern Med, 159, 1467, 10.1001/archinte.159.13.1467

Loeb, 1999, A case-control study to detect modifiable risk factors for colonization with vancomycin-resistant enterococci, Infect Control Hosp Epidemiol, 20, 760, 10.1086/501580

Fridkin, 2001, The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units, Ann Intern Med, 135, 175, 10.7326/0003-4819-135-3-200108070-00009

Lautenbach, 2003, Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins, Clin Infect Dis, 36, 440, 10.1086/346153

Donskey, 2000, Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients, N Engl J Med, 343, 1925, 10.1056/NEJM200012283432604

Bradley, 1999, The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage, J Antimicrob Chemother, 43, 261, 10.1093/jac/43.2.261

Washio, 1997, Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital, Public Health, 111, 187, 10.1016/S0033-3506(97)00581-7

Landman, 1999, Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary, Clin Infect Dis, 28, 1062, 10.1086/514743

Landman, 2002, Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned, Arch Intern Med, 162, 1515, 10.1001/archinte.162.13.1515

Quale, 2002, Molecular epidemiology of a citywide outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection, Clin Infect Dis, 35, 834, 10.1086/342577

Manikal, 2000, Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage, Clin Infect Dis, 31, 101, 10.1086/313902

Saurina, 2000, Antimicrobial resistance in Enterobacteriaceae in Brooklyn, NY: epidemiology and relation to antibiotic usage patterns, J Antimicrob Chemother, 45, 895, 10.1093/jac/45.6.895

Asensio, 2000, Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection, Clin Infect Dis, 30, 55, 10.1086/313590

Schiappa, 1996, Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation, J Infect Dis, 174, 529, 10.1093/infdis/174.3.529

Lautenbach, 2001, Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes, Clin Infect Dis, 32, 1162, 10.1086/319757

Ariffin, 2000, Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia, Int J Infect Dis, 4, 21, 10.1016/S1201-9712(00)90061-4

Paterson, 2004, International prospective study of Klebisella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections, Ann Intern Med, 140, 26, 10.7326/0003-4819-140-1-200401060-00008

Paterson, 2001, Control of an outbreak of infection due to extended-spectrum β-lactamase-producing Escherichia coli in a liver transplantation unit, Clin Infect Dis, 33, 126, 10.1086/320882

Patterson, 2000, Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae, Infect Control Hosp Epidemiol, 21, 455, 10.1086/501787

Rice, 1996, Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center, Clin Infect Dis, 23, 118, 10.1093/clinids/23.1.118

Rahal, 1998, Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella, JAMA, 280, 1233, 10.1001/jama.280.14.1233

Nelson, 1994, Epidemic Clostridium difficile-associated diarrhea: role of second- and third-generation cephalosporins, Infect Control Hosp Epidemiol, 15, 88, 10.2307/30145537

de Lalla, 1989, Third generation cephalosporins as a risk factor for Clostridium difficile-associated disease: a four-year survey in a general hospital, J Antimicrob Chemother, 23, 623, 10.1093/jac/23.4.623

Golledge, 1989, Extended spectrum cephalosporins and Clostridium difficile, J Antimicrob Chemother, 23, 929, 10.1093/jac/23.6.929

Zadik, 1998, Antimicrobial associations of an outbreak of diarrhoea due to Clostridium difficile, J Hosp Infect, 39, 189, 10.1016/S0195-6701(98)90257-2

Settle, 1998, Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam, Aliment Pharmacol Ther, 12, 1217, 10.1046/j.1365-2036.1998.00428.x

Mody, 2001, Clostridium difficile-associated diarrhea in a VA medical center: clustering of cases, association with antibiotic usage, and impact on HIV-infected patients, Infect Control Hosp Epidemiol, 22, 42, 10.1086/501825

Schwaber, 2000, Factors associated with nosocomial diarrhea and Clostridium difficile-associated disease on the adult wards of an urban tertiary care hospital, Eur J Clin Microbiol Infect Dis, 19, 9, 10.1007/s100960050002

Lai, 1997, Clostridium difficile-associated diarrhea: epidemiology, risk factors, and infection control, Infect Control Hosp Epidemiol, 18, 628, 10.1086/647687

Shek, 2000, The rise of Clostridium difficile: the effect of length of stay, patient age, and antibiotic use, J Hosp Infect, 45, 235, 10.1053/jhin.2000.0770

Ludlam, 1999, An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea, Age Ageing, 28, 578, 10.1093/ageing/28.6.578

Graffunder, 2002, Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials, J Antimicrob Chemother, 49, 999, 10.1093/jac/dkf009

Campillo, 2001, Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis, Epidemiol Infect, 127, 443, 10.1017/S0950268801006288

Dziekan, 2000, Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study, J Hosp Infect, 46, 263, 10.1053/jhin.2000.0846

Weber, 2003, Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients, Emerg Infect Dis, 9, 1415, 10.3201/eid0911.030284

Zervos, 2003, Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991–2000, Clin Infect Dis, 37, 1643, 10.1086/379709

Bisognano, 2000, Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin, Antimicrob Agents Chemother, 44, 1428, 10.1128/AAC.44.6.1428-1437.2000

Bisognano, 1997, Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin, Antimicrob Agents Chemother, 41, 906, 10.1128/AAC.41.5.906

Yoo, 1997, Molecular epidemiological analysis of quinolone-resistant Escherichia coli causing bacteremia in neutropenic patients with leukemia in Korea, Clin Infect Dis, 25, 1385, 10.1086/516132

Campillo, 1998, Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin, Clin Infect Dis, 26, 1066, 10.1086/520273

Dupeyron, 1994, Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis, Antimicrob Agents Chemother, 38, 340, 10.1128/AAC.38.2.340

Lautenbach, 2001, Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae, Clin Infect Dis, 33, 1288, 10.1086/322667

Paterson, 2000, Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia, Clin Infect Dis, 30, 473, 10.1086/313719

Villers, 1998, Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology, Ann Intern Med, 129, 182, 10.7326/0003-4819-129-3-199808010-00003

Wiener, 1999, Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes, JAMA, 281, 517, 10.1001/jama.281.6.517

Fink, 1994, Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group, Antimicrob Agents Chemother, 38, 547, 10.1128/AAC.38.3.547

Neuhauser, 2003, Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use, JAMA, 289, 885, 10.1001/jama.289.7.885

Golledge, 1992, Ciprofloxacin and Clostridium difficile-associated diarrhoea, J Antimicrob Chemother, 30, 141, 10.1093/jac/30.2.141

Yip, 2001, Quinolone use as a risk factor for nosocomial Clostridium difficile-associated diarrhea, Infect Control Hosp Epidemiol, 22, 572, 10.1086/501954

Gerding, 2004, Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem, Clin Infect Dis, 38, 646, 10.1086/382084

Gaynes, 2004, Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use, Clin Infect Dis, 38, 640, 10.1086/381551